Journal of clinical and experimental hepatology

· 4 papers in corpus
2025
doi:10.1016/j.jceh.2024.102459 ·PMID:39722783

The global prevalence of metabolic dysfunction-associated steatotic liver disease (MASLD) is rising due to rapid lifestyle changes. Although females may be less prone to MASLD than males, specific studies on MASLD in females should still be…

2022
doi:10.1016/j.jceh.2021.03.003 ·PMID:35068803

The modified derivatives of testosterone, termed as androgenic steroids are indicated in the management of hypogonadism, visceral obesity and metabolic disorders. Anabolic androgenic steroids (AASs) however are surreptitiously used by athle…

2017
doi:10.1016/j.jceh.2017.09.004 ·PMID:29234202

Matrix metalloproteinases (MMPs) are proteinases capable of degrading components of the extracellular matrix and numerous nonmatrix proteins. MMPs along with tissue inhibitors of MMPs, have been implicated in the pathogenesis of liver disea…

2017
doi:10.1016/j.jceh.2017.01.001 ·PMID:28970715

Drug induced liver injury (DILI) is uncommon and severe forms are associated with significant morbidity and mortality. Female sex hormones (estrogens and progestogens) related DILI generally occur with estrogen component. Progesterone compo…